PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.82%
Negative G&A growth (overhead reduction) needs verification. Benjamin Graham would examine impact on operations.
No Data
No Data available this quarter, please select a different quarter.
-166.83%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
-35.81%
Negative operating expenses growth needs verification. Benjamin Graham would examine sustainability.
-35.81%
Negative total costs growth needs verification. Benjamin Graham would examine sustainability.
1.74%
Interest expense growth 0-5% reflects moderate increase. Benjamin Graham would check leverage ratios.
-142558.33%
Negative D&A growth needs verification. Benjamin Graham would examine asset reduction strategy.
-488.78%
Negative EBITDA growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
36.41%
Operating income growth above 15% demonstrates exceptional core profitability. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
2042.35%
Other expenses growth above 30% signals concerning expansion. Seth Klarman would scrutinize unusual items.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.49%
Tax expense growth 0-10% reflects moderate increase. Benjamin Graham would investigate drivers.
439.57%
Net income growth above 15% demonstrates exceptional bottom-line expansion. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
440.81%
EPS growth above 15% demonstrates exceptional shareholder value creation. Warren Buffett would verify sustainability.
440.81%
Diluted EPS growth above 15% demonstrates exceptional value creation despite potential dilution. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.